Sortase A Mediated Protein Modifications and Peptide Conjugations.

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Bioactive peptides regulate physiological processes and possess therapeutic properties like antimicrobial and antitumor activities.
• Traditional peptide production methods face challenges with yield, cost, purification, and synthesis of complex structures like cyclic peptides.
• Prokaryotic transpeptidase Sortase A offers a novel approach for sequence-specific peptide ligation and modification.

Purpose of the Study:

• To review the pharmacological applications of Sortase A in peptide production.
• To highlight Sortase A's utility in overcoming limitations of conventional peptide synthesis.
• To explore Sortase A's role in creating modified peptides for biomedical use.

Main Methods:

• Focus on Sortase A-mediated peptide ligation.
• Review of applications in producing nucleic acid-peptide conjugates, glycosylated peptides, modified proteins/antibodies, and cyclic peptides.
• Discussion of Sortase A's advantages over traditional molecular biology approaches.

Main Results:

• Sortase A enables efficient production of modified peptides, including complex structures.
• The enzyme facilitates applications beyond basic peptide modification, such as molecular sensing and biomaterials.
• Sortase A-mediated ligation improves stability and specificity of therapeutic peptides.

Conclusions:

• Sortase A is a versatile tool for peptide engineering with significant pharmacological potential.
• This enzymatic approach addresses key challenges in producing therapeutic peptides.
• Sortase A-mediated ligation expands the possibilities for designing novel peptide-based therapeutics and biomaterials.